P Ravva

Summary

Affiliation: Pfizer Global Research and Development
Country: USA

Publications

  1. doi request reprint Quantitative assessment of exposure-response relationships for the efficacy and tolerability of varenicline for smoking cessation
    P Ravva
    Global Pharmacometrics, Primary Care Business Unit, Worldwide Pharmaceutical Operations, Pfizer Inc, New London, Connecticut, USA
    Clin Pharmacol Ther 87:336-44. 2010

Detail Information

Publications1

  1. doi request reprint Quantitative assessment of exposure-response relationships for the efficacy and tolerability of varenicline for smoking cessation
    P Ravva
    Global Pharmacometrics, Primary Care Business Unit, Worldwide Pharmaceutical Operations, Pfizer Inc, New London, Connecticut, USA
    Clin Pharmacol Ther 87:336-44. 2010
    ..i.d. the predicted probability of nausea relative to placebo was 24 vs. 7% in male subjects and 40 vs. 14% in female subjects. The incidence of nausea also showed a decreasing trend with time...